Concepedia

G. Fyfe

GF

17

Publications

3.5K

Citations

17

H-Index

1985

Active since

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

Duke University

Sarah Cannon

Kaiser Permanente

National Institutes of Health

G. Fyfe is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, immunology, and oncology.

Top concepts

Publications per year

1985–2010

17

Publications

17

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

G. Fyfe, Richard I. Fisher, S A Rosenberg et al. · Journal of Clinical Oncology · 1995 · 1.4K citations

Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma.

Richard I. Fisher, Steven A. Rosenberg, G. Fyfe · PubMed · 2000 · 441 citations

Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus

Joseph A. Kovacs, Susan Vogel, Jeffrey M. Albert et al. · New England Journal of Medicine · 1996 · 408 citations · Full text

Phase Ib Trial of Intravenous Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor in Combination With Chemotherapy in Patients With Advanced Cancer: Pharmacologic and Long-Term Safety Data

Kim Margolin, Michael Gordon, Eric Holmgren et al. · Journal of Clinical Oncology · 2001 · 366 citations

Subcutaneous Administration of Interleukin‐2 in Human Immunodeficiency Virus Type 1—Infected Persons

Richard T. Davey, Doreen Chaitt, Stephen C. Piscitelli et al. · The Journal of Infectious Diseases · 1997 · 166 citations · Full text

Rows per page

1–5 of 17